ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVBP ArriVent BioPharma Inc

19.532
-0.068 (-0.35%)
Last Updated: 19:58:02
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -23.12M-20.67M-25.7M-24.23M-23.71M
Pre Tax Income -21.19M-17.42M-21.87M-20.56M-20.63M
Net Income -21.19M-17.42M-21.87M-20.56M-20.63M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 00000
EBIT -23.12M-20.67M-25.7M-24.23M-23.71M
EBITDA -23.12M-20.67M-25.7M-24.23M-23.71M
Year End 31 December 2024 202220232024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -36.91M-74.59M-94.31M
Pre Tax Income -36.91M-69.33M-80.49M
Net Income -36.91M-69.33M-80.49M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.125-0.231-0.243
EBIT -36.91M-74.59M-94.31M
EBITDA -36.91M-74.59M-94.31M